The first event in the joint NanoDTC-Impulse-Maxwell Innovation Seminar Series kicks off with a series of brilliant speakers who are at different stages in their Innovation and Entrepreneurship journey.

We will start with brief talks by Tarun Vemulkar, Jeroen Verheyen and Philipp Braeuninger who are NanoDTC Translational Prize winners and will talk about their experience in transitioning from research students to building viable technologies based on their research. Jeroen and Philipp are also alumni of the Impulse Programme.

The talks by these early stage innovators will be followed by our guest speaker who has distinguished herself as leader in research as well as innovation. Prof. Ijeoma Uchegbu is the founding Chief Scientific Officer (CSO) of Nanomerics, a leading startup in the area of pharmaceutical nanotechnology. Ijeoma also holds a chair in Pharmaceutical Nanosciences at UCL and is UCL’s Pro-Vice Provost for Africa and The Middle East.

Nanomerics is a UCL spin out company, which was founded by Ijeoma and Andreas G. Schätzlein. Nanomerics recently licensed its product NM133 to Iacta Pharmaceuticals. Nanomerics also recently won first prize for its Molecular Envelope Technology at the Royal Society of Chemistry’s Emerging Technologies Competition 2017 in the Health category.

Ijeoma has been awarded various prizes for her work, notably the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award, the Royal Pharmaceutical Society’s Pharmaceutical Scientist of the Year 2012 and the Academy of Pharmaceutical Sciences Innovative Science Award 2016. Ijeoma was elected to the Controlled Release Society College of Fellows in 2013 and was made an Eminent Fellow of the Academy of Pharmaceutical Sciences in 2013. Ijeoma is the editor of three books, a named inventor on 11 granted patents and has authored over 120 peer reviewed journal articles and book chapters.

NanoDTC-Impulse-Maxwell Innovation Seminar Series - Prof. Ijeoma Uchegbu, Nanomerics